Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study LANCET ONCOL
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges TRANSPL CELL THER
The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics LIFE-BASEL
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics EUR J HAEMATOL
Coordinated glucocorticoid receptor and MAFB action induces tolerogenesis and epigenome remodeling in dendritic cells NUCLEIC ACIDS RES
Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis LEUKEMIA RES
Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia GENE CHROMOSOME CANC
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity BLOOD ADV
Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries SCI REP-UK